Content Type (RSS): In the News

  • Deals still get done – but only with a new playbook

    Deals still get done – but only with a new playbook

    ARTICLE / CLIENT ALERT

    Deals still get done – but only with a new playbook

    May 29, 2026

    Read time: 7 min

    Key takeaways
    Overview

    Ahead of SuperReturn Berlin 2026, private equity faces an execution environment where structure, financing, and judgment are the real differentiators.

    Execution has become the defining capability

    As we are approaching the third quarter of this year, one theme stands out. Across private equity, transactions are progressing, but they are taking different paths to the finish line. Timelines are longer, due diligence is more extensive, structures are more complex, and risks are harder to price. In many cases, deals only close because the parties involved are willing to rethink the conventional approach.

    The question is no longer whether capital is available or whether assets are attractive. The real question is whether deals can be executed – and how they can be successfully brought to completion in today’s challenging market environment.

    The investors that succeed are not necessarily those with the most capital or the strongest pipeline. They are the ones that can navigate complexity without losing momentum.

    There is no longer a “standard” deal

    Expectations of a traditional buyout model with clean pricing and straightforward leverage are increasingly out of step with market reality.

    Today’s transactions are bespoke by necessity. Valuation gaps persist, sellers want certainty, and buyers want protection. Bridging that tension requires flexibility.

    As a result, the market is seeing a clear shift towards:

    • Earnouts and deferred consideration to align expectations on future performance;
    • Minority positions and staged acquisitions where conviction exists but certainty does not;
    • Joint ventures and co-investment structures to share risk and unlock opportunities;
    • Rollover equity and seller financing to keep stakeholders invested in the outcome; and
    • More complex capital structures covering the full spectrum from senior loans to PIK structures and structured equity.

    These tools are not new. What has changed is how frequently they are used, how they interplay and how central they have become to getting deals signed.

    For investors, this means structure is no longer a secondary consideration. It is often the mechanism that determines whether a deal happens at all.

    Financing is shaping the deal as much as the asset

    Financing used to follow the deal. Now it often defines it.

    While traditional lenders remain active, they have become more selective, and the terms are getting tighter. In response, private equity has leaned more heavily into alternative capital, including private credit, hybrid instruments, and structured equity.

    That shift brings flexibility, but also complexity.

    Different capital providers come with different expectations on control, return, and downside protection. Intercreditor arrangements are more nuanced. Covenant packages are more tailored. And in many cases, financing terms directly influence how the transaction is structured.

    For dealmakers, this means financing strategy must be embedded early. Leaving it too late introduces execution risk that is increasingly difficult to unwind.

    Diligence is broader, deeper, and harder to compress

    One of the most significant shifts is in diligence.

    Financial and legal fundamentals remain critical, but ticking the boxes is no longer sufficient, as stakeholders increasingly expect to understand a target’s exposure to a wider set of risks that can affect both value and viability.

    Two areas consistently rise to the top:

    • Environmental, social, and governance considerations are now seen as a core part of the deal analysis – and not a box-ticking exercise – affecting valuation, structure, and exit planning. This shift is driven by regulation, investor expectations, and reputational considerations.
    • Cybersecurity and data risk have also moved to the center. Decision-makers are interested not only in whether issues exist, but also in how resilient the business is, how data flows across jurisdictions, and how regulatory regimes apply.

    In addition, several other areas are becoming more critical for decision-makers:

    • AI resilience is emerging as both an opportunity and a source of fragility. Stakeholders want to know whether target companies have control over their data, models, and dependencies, and whether they are exposed to third-party risk, weak governance, and unproven use cases.
    • Geopolitical exposure can also directly impact value. The focus is on vulnerability to regulatory shifts, trade restrictions, and supply chain disruption, as well as the ability to reconfigure operations if conditions change.
    • Market resilience is increasingly central to underwriting the investment case, as pricing power, customer concentration, and cyclicality determine how quickly performance deteriorates under stress.

    These factors are no longer peripheral, as they directly affect downside protection, valuation, and the credibility of the investment thesis. This shift requires sponsors to manage a significantly broader and more interconnected diligence scope – without slowing down the deal to a point where opportunity is lost.

    Cross-border deals carry more friction than before

    Europe remains a highly attractive market, but cross-border execution is more complex than it was even a few years ago.

    Foreign investment screening regimes, antitrust reviews, and sector-specific regulations are evolving quickly; approval processes can be unpredictable in both timing and outcome; and political considerations can also influence decision-making in ways that are difficult to model.

    At the same time, differences in legal systems, tax frameworks, and business culture continue to shape negotiations and integration.

    For investors, this means jurisdictional strategy is no longer a late-stage workstream. It needs to be built into the deal from the outset, with clear planning around approvals, conditions, and fallback positions.

    The deals that close are the ones that adapt

    Despite all of this, deals are still getting done, but they close because the parties involved are willing to adapt – sometimes significantly – from their initial positions.

    In practice, that means:

    • Designing structures that can flex if conditions change between signing and closing;
    • Sequencing steps to manage financing and regulatory timelines more effectively;
    • Using conditionality in a targeted way to balance protection with certainty; and
    • Keeping stakeholders aligned as terms evolve.

    What distinguishes successful execution today is not just technical precision, it is judgment: knowing where to push, where to compromise, and how to keep a transaction moving forward when the path is no longer straightforward.

    Execution has become a real source of value

    As conversations in Berlin will reflect, the market has not disappeared. It has simply become more demanding.

    A well-structured deal can preserve value in a volatile environment. A poorly executed one can erode it quickly, regardless of the underlying asset. As a result, returns are increasingly influenced by how well deals are executed, not just what is acquired.

    In a market defined by complexity, execution is no longer the final step in the process. It is the strategy.

    For private equity, this is a shift worth recognizing.

    The McDermott difference

    Private equity transactions are not getting simpler, but with the right approach, they are still getting done.

    McDermott Will & Schulte works alongside investors to navigate this complexity with a clear focus on execution. That means aligning structure, financing, and risk allocation with your commercial objectives from the outset and maintaining momentum through each stage of the deal. When challenges arise, the focus is on resolving them quickly and pragmatically, so the transaction keeps moving.

    With an integrated, cross-border team, McDermott brings together the legal, regulatory, tax, and financing perspectives that modern deals demand. From first thesis to exit, our goal remains consistent: to help you manage risk, unlock opportunity, and deliver transactions that close with certainty in an increasingly complex market.

    Learn more about our private equity capabilities, and feel free to reach out to us.

    Our team will be attending the SuperReturn 2026 in Berlin and looks forward to discussing the latest developments shaping the private equity market. If you will be in Berlin as well, feel free to reach out to us to connect during the conference.

    In depth
    Authors
    More insights

  • Global employers face mounting AI compliance pressure: IBA reports

    Global employers face mounting AI compliance pressure: IBA reports

    COVERAGE

    Global employers face mounting AI compliance pressure: IBA reports

    May 28, 2026

    Read time: 2 min

    About Us

    Todd A. Solomon

    Partner

    Chicago

    You may also like

  • McDermott-led Ampersand clinches $1.5b fund

    McDermott-led Ampersand clinches $1.5b fund

    COVERAGE

    McDermott-led Ampersand clinches $1.5b fund

    May 28, 2026

    Read time: 2 min

    About Us

    Jason S. Kaplan

    Partner

    New York – 919 Third Avenue

    Marc E. Elovitz

    Partner

    New York – 919 Third Avenue

    David S. Wermuth

    Partner

    New York – 919 Third Avenue

    Kristian A. Werling

    Partner

    Chicago

    Michael S. Jaroslawicz

    Partner

    New York – 919 Third Avenue

    Nick Fagge

    Partner

    London – One Eagle Place

    David M. Cohen

    Partner

    New York – 919 Third Avenue

    You may also like

  • McDermott Will & Schulte represents Ampersand Capital Partners in close of oversubscribed fund at $1.5 billion hard cap

    McDermott Will & Schulte represents Ampersand Capital Partners in close of oversubscribed fund at $1.5 billion hard cap

    DEAL ANNOUNCEMENT

    McDermott Will & Schulte represents Ampersand Capital Partners in close of oversubscribed fund at $1.5 billion hard cap

    May 28, 2026

    Read time: 4 min

    McDermott Will & Schulte represented Ampersand Capital Partners, a middle-market private equity firm dedicated to growth in the healthcare sector, in the formation of Ampersand 2026 Limited Partnership with $1.5 billion in limited partner commitments. This oversubscribed fund, which is Ampersand’s twelfth primary fund since 1992, held a single close at the hard cap less than 5 months after launch.

    The McDermott team was led by Jason Kaplan, Marc Sana, Marc Elovitz, David Wermuth, Kristian Werling, and Michael Jaroslawicz, with invaluable assistance from Sarah Heberlig, Jimmy Aiosa, Eric Wesson, Joseph Daly, Kyle Hendrix, Matthew Schecter, Eric Choi, Nick Fagge, and David Cohen.

    Read the press release here.

    About Us

    Leading organizations turn to global law firm McDermott Will & Schulte for a better way to address legal challenges, connect with those at the forefront, and drive stronger outcomes. Working across more than 20 offices globally, our 1,700+ lawyers act on data-driven insights, deep relationships, and unmatched industry experience to deliver on our commitment of Always Better.

    Jason S. Kaplan

    Partner

    New York – 919 Third Avenue

    Marc Sana

    Associate

    New York – 919 Third Avenue

    Marc E. Elovitz

    Partner

    New York – 919 Third Avenue

    David S. Wermuth

    Partner

    New York – 919 Third Avenue

    Kristian A. Werling

    Partner

    Chicago

    Michael S. Jaroslawicz

    Partner

    New York – 919 Third Avenue

    Eric B. Wesson

    Associate

    New York – 919 Third Avenue

    Joseph Daly

    Associate

    Nashville

    Kyle B. Hendrix

    Associate

    Washington, DC

    Matthew I. Schecter

    Associate

    New York – 919 Third Avenue

    Nick Fagge

    Partner

    London – One Eagle Place

    David M. Cohen

    Partner

    New York – 919 Third Avenue

    You may also like

  • Sold inventory may drive tax treatment of tariff refunds

    Sold inventory may drive tax treatment of tariff refunds

    COVERAGE

    Sold inventory may drive tax treatment of tariff refunds

    May 27, 2026

    Read time: 2 min

    About Us

    Jeffrey Maydew

    Partner

    Chicago

    Elizabeth Chao

    Partner

    Chicago

    Akiva B. Ungar

    Associate

    Chicago

    You may also like

  • Henry Smokler discusses the growing demand for MLB franchises in The Athletic

    Henry Smokler discusses the growing demand for MLB franchises in The Athletic

    COVERAGE

    Henry Smokler discusses the growing demand for MLB franchises in The Athletic

    May 27, 2026

    Read time: 3 min

    In a recent article in The Athletic, partner Henry Smokler provides insight into the economic forces driving Major League Baseball (MLB) franchise valuations to record highs – and why owners are pushing for a salary cap ahead of the next round of collective bargaining negotiations.

    The article examines why MLB team values continue to climb despite lagging behind NFL and NBA franchises in revenue multiples, exploring the influence of private equity, media rights, and the growing pool of ultra-high-net-worth buyers seeking entry into professional sports. Henry attributed the surge to a fundamental supply-and-demand imbalance. “It’s scarcity,” he told The Athletic. “There hasn’t been a lot of expansion. There’s just more buyers, more billionaires, more demand and not an increase in supply.”

    About Us
    You may also like

  • MLB owners want what NBA, NFL owners have: soaring franchise values, and a salary cap

    MLB owners want what NBA, NFL owners have: soaring franchise values, and a salary cap

    COVERAGE

    MLB owners want what NBA, NFL owners have: soaring franchise values, and a salary cap

    May 27, 2026

    Read time: 2 min

    About Us
    You may also like

  • McDermott Will & Schulte represents Texture in its $12.5M Series A financing

    McDermott Will & Schulte represents Texture in its $12.5M Series A financing

    DEAL ANNOUNCEMENT

    McDermott Will & Schulte represents Texture in its $12.5M Series A financing

    May 27, 2026

    Read time: 3 min

    McDermott Will & Schulte advised Texture in connection with its $12.5M Series A financing round led by VoLo Earth and Equal Ventures, with Lerer Hippeau and Abstract Ventures doubling down. Texture is the connected control system for modern grid operations, built for the teams responsible for keeping energy flowing.

    The McDermott team was led by Alexei Cowett with invaluable assistance from Oliver Cheng.

    About Us

    Leading organizations turn to global law firm McDermott Will & Schulte for a better way to address legal challenges, connect with those at the forefront, and drive stronger outcomes. Working across more than 20 offices globally, our 1,700+ lawyers act on data-driven insights, deep relationships, and unmatched industry experience to deliver on our commitment of Always Better.

     

    Alexei Cowett

    Partner

    Washington, DC, New York – One Vanderbilt Avenue

    Oliver Cheng

    Associate

    San Francisco

    You may also like

  • McDermott advises Almirall on collaboration with Huaota

    McDermott advises Almirall on collaboration with Huaota

    DEAL ANNOUNCEMENT / PRESS RELEASE

    McDermott advises Almirall on collaboration with Huaota

    May 27, 2026

    Read time: 3 min

    Frankfurt, May 27, 2026 — McDermott Will & Schulte advised Spanish biopharmaceutical company Almirall, S.A. on entering into a collaboration with Chinese company Huaota Biopharmaceutical Co., Ltd., a subsidiary of Zhejiang Huahai Pharmaceutical Co., Ltd., for the development of a novel monoclonal antibody for medical dermatology.

    The collaboration focuses on a joint R&D program for a monoclonal antibody candidate. Huaota will lead early-stage research activities and the initial phases of clinical development and will receive development and commercialization rights for China. Almirall retains worldwide development and commercialization rights outside of China.

    Total payments from Almirall to Huaota could amount to up to $340 million, including upfront and milestone payments tied to the success of development and commercialization, as well as tiered royalties on future net sales. Huaota will pay Almirall tiered royalties based on potential future sales of the product in China.

    Publicly traded Almirall, headquartered in Barcelona, is a global pharmaceutical company dedicated to medical dermatology. With more than 2,100 employees worldwide, the company generated total revenue of over €1.1 billion in 2025.

    The McDermott team advising Almirall was led by partner Monika Richter.

    About Us

    Leading organizations turn to global law firm McDermott Will & Schulte for a better way to address legal challenges, connect with those at the forefront, and drive stronger outcomes. Working across more than 20 offices globally, our 1,700+ lawyers act on data-driven insights, deep relationships, and unmatched industry experience to deliver on our commitment of Always Better.

    You may also like

  • McDermott and Pavia e Ansaldo in the acquisition of Scriba

    McDermott and Pavia e Ansaldo in the acquisition of Scriba

    DEAL ANNOUNCEMENT

    McDermott and Pavia e Ansaldo in the acquisition of Scriba

    May 27, 2026

    Read time: 3 min

    McDermott Will & Schulte, with a team led by Vincenzo Giannantonio and Giulia Fossati Zunino and composed of Vera Greco and Sofia Cecchet, who handled all corporate and M&A aspects of the transaction, as well as Domenico Patruno, who oversaw the banking aspects, assisted the La Prensa Group (owned, among others, by Unigrains and BNP Paribas BNL Equity Investments), a leading company in Italy in the printing and finishing of labels for various types of products, mainly food and pet food, in the acquisition of the entire share capital of Scriba.

    The transaction is part of La Prensa Group’s consolidation strategy as a leading operator in the sector, with the aim of strengthening its market presence through the integration of industrial and commercial expertise, thereby enhancing its competitive advantage.

    The sellers were assisted by Pavia e Ansaldo with a team composed of Giuseppe Besozzi, Erica Lepore, and Roberta Rotunno.

    The notarial aspects were handled by Notary Ciro De Vivo and lawyer Mario Lado of the Notarial Firm Ciro De Vivo.

    Bernoni Grant Thornton (with a team composed of Gianni Bitetti, Sara Flisi, and Valentina Adly) acted as tax advisor to the buyers, while Grant Thornton Financial Advisory Services acted as financial advisor.

    Millelire Corporate Finance, with a team composed of Andrea Muncher and Paola Sulpizio, served as financial and M&A advisor to the sellers.

    About Us

    Leading organizations turn to global law firm McDermott Will & Schulte for a better way to address legal challenges, connect with those at the forefront, and drive stronger outcomes. Working across more than 20 offices globally, our 1,700+ lawyers act on data-driven insights, deep relationships, and unmatched industry experience to deliver on our commitment of Always Better.

    You may also like